Company / Capital Expenditures
BioCardia, Inc. Capital Expenditures History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$136.0K
FY2017
5-year range
$136.0K / $137.0K
FY2013-FY2017
Trend
-
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$136,000 in FY2017.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $136.0K | - |
| FY2016 | - | - |
| FY2011 | $137.0K | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026